HAYWARD, Calif., May 2, 2011 /PRNewswire/ -- Solta Medical, Inc.
(Nasdaq: SLTM), a global leader in the medical aesthetics market,
today announced that it will present at the Tenth Annual JMP
Securities Research Conference at the Ritz-Carlton in San Francisco on Monday, May 9, 2011 at 1:00 pm Pacific Time. Stephen J. Fanning, Chairman, President and
Chief Executive Officer, will review the company's business
strategy and recent corporate events.
Attendance at this conference is by invitation only. Solta will
offer a live audio webcast of its presentation which may be
accessed at the Investor Relations section of the Company's website
at www.solta.com. An archived replay of the presentation will be
available for 15 days, also at www.solta.com.
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics
market providing innovative, safe, and effective solutions for
patients that enhance and expand the practice of medical aesthetics
for physicians. The company offers products to address a range of
skin issues under the industry's four premier brands: Thermage®,
Fraxel®, Isolaz®, and CLARO®. Thermage is an innovative,
non-invasive radiofrequency procedure for tightening and contouring
skin. As the leader in fractional laser technology, Fraxel delivers
minimally invasive clinical solutions to resurface aging and sun
damaged skin. Isolaz is the first laser or light based system
indicated for the treatment of inflammatory acne, comedonal acne,
pustular acne, and mild-to-moderate inflammatory acne. CLARO is a
personal care acne system that is the first FDA cleared
over-the-counter IPL device that uses a powerful combination of
both heat and light to clear skin quickly and naturally. Since
2002, over one million Thermage, Fraxel and Isolaz procedures have
been performed in over 100 countries. For more information about
Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.
SOURCE Solta Medical, Inc.